USC Researchers Reveal Only 15% of NIH AI Grants Reach Clinical Use

A USC team used GPT-4o-mini to classify 58,746 NIH grants, finding AI gets a 13.4% funding premium but barely reaches clinics.

·
·
·
USC Researchers Reveal Only 15% of NIH AI Grants Reach Clinical UsePRO
Read2 min
TypePaper
  • USC analysis of 58,746 NIH grants finds AI makes up 15.9% of the FY2025 portfolio.
  • AI projects receive a 13.4% funding premium: $675K mean award versus $595K for non-AI work.
  • 79% of AI grants stay in research stage; only 14.7% reach clinical deployment or implementation.
  • Cancer, aging, and mental health capture 50.1% of AI funding; health disparities gets just 5.7%.
  • Two-pass GPT-4o-mini pipeline screens abstracts, then extracts structured JSON rubric fields.
  • Human-in-the-loop recoding cut unclassified "Other" projects from 41.5% to 17.7%.

Two researchers at USC’s Information Sciences Institute used a large language model pipeline to classify all 58,746 NIH-funded projects listed for fiscal year 2025. Their portfolio analysis identified 9,363 projects with a substantive AI or machine learning component, then mapped their funding, disease areas, development stages, methods, and institutional collaborations. The results show where NIH-backed AI work is concentrated and how little of it has reached clinical implementation.

One in six projects uses AI

AI-related work accounted for 15.9% of the NIH projects studied. Those projects received an average award of $675,129, which was 13.4% higher than the $595,135 average for projects outside the AI classification.

Classification Projects Portfolio share Mean award
AI-related 9,363 15.9% $675,129
Other projects 49,383 84.1% $595,135

Cancer and oncology represented the largest AI research area, followed by aging and neurodegenerative disease, mental health and substance use disorders, neuroscience, and infectious disease.

Research area Projects Share of AI projects
Cancer and oncology 1,814 19.4%
Aging and neurodegenerative disease 1,572 16.8%
Mental health and substance use disorders 1,393 14.9%
Neuroscience 1,033 11.0%
Infectious disease 1,024 10.9%

Health disparities and minority health research received 5.7% of AI funding, despite its status as an NIH priority.

Charts showing AI adoption, funding, research stages, and disease areas across the NIH portfolio
AI adoption and funding across the fiscal year 2025 NIH portfolio.

Clinical deployment gets a narrow slice

Most AI projects remained in research or development. The authors classified 7,393 projects, or 79.0%, in that stage. Clinical deployment or implementation accounted for 1,372 projects, or 14.7%.

Pro article

This story is for Pro members

You've reached the end of the free preview. Upgrade to AlphaSignal Pro to read the full article - and everything else behind the paywall.

Trending
  • No trending articles

Comments

avatar

Next Reads